Skip to main content
See every side of every news story
Published • loading... • Updated

Moderna’s experimental RSV vaccines face fresh safety questions over infant trial

Fresh concerns have emerged over the safety of Moderna’s experimental respiratory syncytial virus (RSV) vaccines for infants following the disclosure of 13 suspected serious adverse drug reactions recorded during a clinical trial in the United Kingdom. The latest information, obtained from the UK Medicines and Healthcare products Regulatory Agency (MHRA), has raised questions about the safety monitoring and reporting of the trial, which was susp…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

National Daily Newspaper broke the news on Saturday, November 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal